tiprankstipranks
Trending News
More News >
Ramm Pharma (TSE:RAMM)
:RAMM
Canadian Market
Advertisement

Ramm Pharma (RAMM) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
3Neutral
6Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Ramm Pharma’s (RAMM) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Ramm Pharma is a Buy.
Ramm Pharma’s (RAMM) 20-Day exponential moving average is 0.06, while Ramm Pharma’s (RAMM) share price is <C$0.1, making it a Buy.
Ramm Pharma’s (RAMM) 50-Day exponential moving average is 0.04, while Ramm Pharma’s (RAMM) share price is <C$0.1, making it a Buy.

Ramm Pharma (RAMM) Pivot Points

Dec 04, 2025, 05:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Fibonacci
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ramm Pharma (RAMM) Moving Averages

Dec 04, 2025, 05:38 AM
Period
Simple
Exponential
MA5
0.07Sell
0.07Sell
MA10
0.07Sell
0.07Sell
MA20
0.06Buy
0.06Buy
MA50
0.03Buy
0.04Buy
MA100
0.02Buy
0.03Buy
MA200
0.02Buy
0.02Buy
Ramm Pharma’s (RAMM) 10-Day exponential moving average is 0.07, while Ramm Pharma’s (RAMM) share price is <C$0.1, making it a Sell.
Ramm Pharma’s (RAMM) 100-Day exponential moving average is 0.03, while Ramm Pharma’s (RAMM) share price is <C$0.1, making it a Buy.
Ramm Pharma’s (RAMM) stock price is <C$0.1 and Ramm Pharma’s (RAMM) 50-day simple moving average is 0.03, creating a Buy signal.
Ramm Pharma’s (RAMM) stock price is <C$0.1 and Ramm Pharma’s (RAMM) 100-day simple moving average is 0.02, creating a Buy signal.
Ramm Pharma’s (RAMM) stock price is <C$0.1 and Ramm Pharma’s (RAMM) 200-day simple moving average is 0.02, creating a Buy signal.

Ramm Pharma (RAMM) Technical Indicators

Dec 04, 2025, 05:38 AM
Name
Value
Implied Action
RSI (14)
54.57
Neutral
STOCH (9,6)
30.00
Neutral
STOCHRSI (14)
19.15
Buy
MACD (12,26)
0.01
Buy
ADX (14)
56.26
Sell
Williams %R
-80.85
Buy
CCI (14)
7.35
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
70.73
Buy
ROC
200.00
Buy
Ramm Pharma’s (RAMM) Relative Strength Index (RSI) is 54.57, creating a Neutral signal.
Ramm Pharma’s (RAMM) Trend Strength Indicator (ADX) is 56.26, creating a Sell signal.
Ramm Pharma’s (RAMM) Commodity Channel Index (CCI) is 7.35, creating a Neutral signal.
Ramm Pharma’s (RAMM) Price Rate of Change (ROC) is 200.00, creating a Buy signal.

FAQ

Is RAMM a Buy, Hold, or Sell?
Based on RAMM’s technical indicators, RAMM is a Buy.
    What is RAMM’s RSI (14)?
    RAMM’s RSI (14) is 54.57, which suggests RAMM is a Neutral.
      What is RAMM’s MACD?
      RAMM’s MACD is 0.01, which suggests RAMM is a Buy.
        What is RAMM’s 5-day moving average?
        RAMM’s 5-day moving average is 0.07, which suggests RAMM is a Sell.
          What is RAMM’s 20-day moving average?
          RAMM 20-day moving average is 0.06, which suggests RAMM is a Buy.
            What is RAMM’s 50-day moving average?
            RAMM’s 50-day moving average is 0.03, which suggests RAMM is a Buy.
              What is RAMM’s 200-day moving average?
              RAMM’s 200-day moving average is 0.02, which suggests RAMM is a Buy.
                What is RAMM’s Williams % R (14)?
                RAMM’s Williams % R (14) is -80.85, which suggests RAMM is a Buy.
                  What is RAMM’s CCI (14)?
                  RAMM’s CCI (14) is 7.35, which suggests RAMM is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis